Schreck Michael 4

Accession 0000874716-25-000028

CIK 0000874716other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:43 PM ET

Size

28.8 KB

Accession

0000874716-25-000028

Form 4

Period: 2025-02-13

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2025-02-14+80→ 1,018 total
Exercise/Conversion
Common Stock
2025-02-14+791→ 1,926 total
Exercise/Conversion
Common Stock
2025-02-14+301→ 2,397 total
Award
Non-Qualified Stock Option (right-to-buy)
2025-02-13+6,320→ 6,320 total
Exercise: $459.76Exp: 2035-02-12→ Common Stock (6,320 underlying)
Award
Restricted Stock Unit
2025-02-13+1,468→ 1,468 total
→ Common Stock (1,468 underlying)
Exercise/Conversion
Common Stock
2025-02-14+117→ 1,135 total
Exercise/Conversion
Common Stock
2025-02-14+170→ 2,096 total
Tax Payment
Common Stock
2025-02-14$444.53/sh−441$196,038→ 1,956 total
Exercise/Conversion
Restricted Stock Unit
2025-02-14−80→ 0 total
→ Common Stock (80 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−117→ 117 total
→ Common Stock (117 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−791→ 0 total
→ Common Stock (791 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−170→ 338 total
→ Common Stock (170 underlying)
Award
Incentive Stock Option (right-to-buy)
2025-02-13+217→ 217 total
Exercise: $459.76Exp: 2035-02-12→ Common Stock (217 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−301→ 903 total
→ Common Stock (301 underlying)

Footnotes (8)

[F1]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
[F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
[F3]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
[F4]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four equal annual installments beginning on February 14, 2022.
[F5]Each RSU represents a contingent right to receive one share of Issuer. common stock and vests in four equal annual installments beginning on February 14, 2023.
[F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2025.
[F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024.
[F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.

Documents

1 file

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother